Do Histology and Primary Tumor Location Influence Metastatic Patterns in Bladder Cancer?
-
Published:2023-10-11
Issue:10
Volume:30
Page:9078-9089
-
ISSN:1718-7729
-
Container-title:Current Oncology
-
language:en
-
Short-container-title:Current Oncology
Affiliation:
1. Department of Pathology, Chungnam National University School of Medicine, Daejeon 35015, Republic of Korea
Abstract
Metastasis is the leading cause of death in patients with bladder cancer. This study utilized a statistical analysis of patient data from the Surveillance, Epidemiology, and End Results database to examine the influence of histological type and primary site on the metastatic behavior of bladder cancer. Significantly different metastatic patterns were observed among bladder cancer patients depending on their histological type. Patients with squamous cell carcinoma showed a significantly (p < 0.001) lower bone metastasis rate (27.2%) than patients with urothelial carcinoma (UC) (38.3%). Patients with neuroendocrine carcinoma showed a significantly (p < 0.001) higher liver metastasis rate (52.1%) and a significantly (p = 0.001) lower lung metastasis rate (25.7%) than patients with UC (22.6% and 33.5%, respectively). UC patients also demonstrated differences in metastatic behavior according to histological subtype. The sarcomatoid subtype showed a significantly (p < 0.001) higher lung metastasis rate (51.6%) and a significantly lower (p = 0.002) lymph node metastasis rate (22.6%) than the micropapillary subtype (12.1% and 54.1%, respectively). Significant differences in metastatic behavior were also observed among patients with conventional UCs originating from the bladder, ureter, and renal pelvis. This study highlights the impact of histological characteristics and primary site on metastatic tendencies in bladder cancer, highlighting the importance of tailoring treatment and surveillance strategies.
Funder
Chungnam National University Hospital Research Fund
Reference39 articles.
1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA Cancer J. Clin.,2021 2. Saginala, K., Barsouk, A., Aluru, J.S., Rawla, P., Padala, S.A., and Barsouk, A. (2020). Epidemiology of Bladder Cancer. Med. Sci., 8. 3. Aveta, A., Cacciapuoti, C., Barone, B., Di Zazzo, E., Del Giudice, F., Maggi, M., Ferro, M., Terracciano, D., Busetto, G.M., and Lucarelli, G. (2022). The Impact of Meat Intake on Bladder Cancer Incidence: Is It Really a Relevant Risk?. Cancers, 14. 4. Histologic Variants of Urothelial Bladder Cancer and Nonurothelial Histology in Bladder Cancer;Chalasani;Can. Urol. Assoc. J.,2009 5. Flammia, R.S., Tufano, A., Chierigo, F., Würnschimmel, C., Hoeh, B., Sorce, G., Tian, Z., Anceschi, U., Leonardo, C., and Del Giudice, F. (2023). The Effect of Sex on Disease Stage and Survival after Radical Cystectomy in Non-Urothelial Variant-Histology Bladder Cancer. J. Clin. Med., 12.
|
|